10.31

0.98% 0.10

After Hours: 10.39 0.08 +0.78%

Rocket Pharmaceuticals Inc (RCKT)

Overview News Price History Option Chain Financials Discussions Forecast Stock Split

Rocket Pharmaceuticals Inc stock is traded at $10.31, with a volume of 1.72M. It is up +0.98% in the last 24 hours and down -13.51% over the past month. Rocket Pharmaceuticals Inc is a late-stage biopharmaceutical company. It is focused on the development of gene therapies for rare and devastating pediatric diseases. The pipeline products of the company include RP-A501 for Danaon Disease, RP-L102 for Fanconi Anemia, RP-L201 for Leukocyte Adhesion, RP-L301 for Pyruvate Kinase Deficiency, and RP-L401 for Infantile Malignant Osteopetrosis.

Previous Close:

$10.21

Open:

$10.34

24h Volume:

1.72M

Relative Volume:

1.43

Market Cap:

$1.10B

Revenue:

Net Income/Loss:

$-249.31M

P/E Ratio:

-3.5923

EPS:

-2.87

Net Cash Flow:

$-209.70M

1W Performance:

-7.45%

1M Performance:

-13.51%

6M Performance:

-56.30%

1Y Performance:

-62.22%

1-Day Range:

$10.14

$10.61

1-Week Range:

$10.12

$11.24

52-Week Range:

$10.12

$31.47

Rocket Pharmaceuticals Inc Stock (RCKT) Company Profile

Name

Rocket Pharmaceuticals Inc

Sector

Healthcare (1174)

Industry

Biotechnology (684)

Phone

646-440-9100

Address

350 FIFTH AVENUE, NEW YORK, NY

Employee

268

Twitter

@rocketpharma

Next Earnings Date

2024-11-04

Latest SEC Filings

RCKT's Discussions on Twitter

Compare RCKT with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
RCKT Rocket Pharmaceuticals Inc	10.31	1.10B	0	-249.31M	-209.70M	-2.87
VRTX Vertex Pharmaceuticals Inc	422.00	108.68B	10.63B	-479.80M	-1.35B	-1.99
REGN Regeneron Pharmaceuticals Inc	681.58	74.90B	13.85B	4.65B	3.32B	40.41
ARGX Argen X Se Adr	640.52	38.30B	1.86B	-40.29M	-1.28B	-0.85
ALNY Alnylam Pharmaceuticals Inc	246.27	31.76B	2.09B	-332.26M	16.06M	-2.62
BNTX Biontech Se Adr	111.93	26.83B	3.30B	-501.07M	1.03B	-2.1146

Rocket Pharmaceuticals Inc Stock (RCKT) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Dec-30-24	Initiated	Wedbush	Outperform
Dec-18-24	Initiated	Jefferies	Buy
Oct-16-24	Initiated	Scotiabank	Sector Outperform
Apr-02-24	Initiated	Goldman	Neutral
Oct-24-23	Initiated	Cantor Fitzgerald	Overweight
Feb-01-23	Initiated	Morgan Stanley	Overweight
Nov-08-22	Initiated	Canaccord Genuity	Buy
Nov-01-22	Initiated	BTIG Research	Buy
Jul-08-22	Initiated	Raymond James	Outperform
Oct-20-21	Resumed	Cowen	Outperform
Mar-02-21	Initiated	Stifel	Buy
Feb-18-21	Initiated	Needham	Buy
Dec-16-20	Initiated	UBS	Buy
Dec-08-20	Downgrade	Oppenheimer	Outperform → Perform
Jul-02-20	Initiated	JP Morgan	Overweight
Jun-25-20	Resumed	BofA/Merrill	Buy
Jun-01-20	Resumed	Oppenheimer	Outperform
Nov-06-19	Initiated	Chardan Capital Markets	Buy
Sep-26-19	Initiated	Piper Jaffray	Overweight
Apr-23-19	Initiated	Robert W. Baird	Outperform
Mar-15-19	Initiated	BofA/Merrill	Buy
Feb-05-19	Initiated	Oppenheimer	Outperform
Sep-13-18	Initiated	Ladenburg Thalmann	Buy
Jul-10-18	Initiated	William Blair	Outperform

View All

Rocket Pharmaceuticals Inc Stock (RCKT) Latest News

Jan 19, 2025

Rocket Pharmaceuticals (NASDAQ:RCKT) Sets New 12-Month Low – Time to Sell? - Defense World

Jan 19, 2025

Jan 17, 2025

Rocket Pharmaceuticals (NASDAQ:RCKT) Stock Price Down 4%Here's Why - MarketBeat

Jan 17, 2025

How to Take Advantage of moves in (RCKT) - Stock Traders Daily

Jan 17, 2025

Rocket Pharmaceuticals (NASDAQ:RCKT) Sets New 52-Week LowHere's Why - MarketBeat

Jan 17, 2025

Jan 16, 2025

Rocket Pharmaceuticals (RCKT) Loses -12.5% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner - MSN

Jan 16, 2025

Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT) Shares Acquired by Mirador Capital Partners LP - MarketBeat

Jan 16, 2025

Jan 13, 2025

JPMorgan Chase & Co. Decreases Position in Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT) - Defense World

Jan 13, 2025

Jan 10, 2025

Rocket Pharmaceuticals (NASDAQ:RCKT) Hits New 12-Month LowHere's What Happened - MarketBeat

Jan 10, 2025

Jan 07, 2025

Rocket Pharmaceuticals (NASDAQ:RCKT) Shares Up 6.9%Time to Buy? - MarketBeat

Jan 07, 2025

Jan 06, 2025

Learn to Evaluate (RCKT) using the Charts - Stock Traders Daily

Jan 06, 2025

RCKTRocket Pharmaceuticals, Inc. Latest Stock News & Market Updates - StockTitan

Jan 06, 2025

Jan 02, 2025

Rocket Pharmaceuticals to Participate in the 43rd Annual J.P. Morgan Healthcare Conference - BioSpace

Jan 02, 2025

Q4 Earnings Estimate for RCKT Issued By Wedbush - Defense World

Jan 02, 2025

Jan 01, 2025

Brokers Set Expectations for RCKT Q4 Earnings - MarketBeat

Jan 01, 2025

Dec 31, 2024

Rocket Pharmaceuticals (NASDAQ:RCKT) Trading 3.7% HigherWhat's Next? - MarketBeat

Dec 31, 2024

Wedbush starts Rocket Pharmaceuticals with Outperform into ‘inflection year’ - Yahoo Finance

Dec 31, 2024

Rocket Pharmaceuticals (NASDAQ:RCKT) Now Covered by Analysts at Wedbush - Defense World

Dec 31, 2024

Dec 30, 2024

Rocket Pharmaceuticals' SWOT analysis: gene therapy stock poised for growth - Investing.com Canada

Dec 30, 2024

Rocket Pharmaceuticals (NASDAQ:RCKT) Now Covered by Wedbush - MarketBeat

Dec 30, 2024

Dec 29, 2024